| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f985f3aa03fabe4938c2b70b423960b9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2013-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61d72d4be982b0a62de2391bbc476607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96245254d706187f368a97cbc5ccd563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c8e3fc00127c8c15c57d1b647c895ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc70371f11e22b7baab1c24e0fe5ce92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06e9dfe0e3b24831f1db74ca79afc4f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fdc7439bdf471a103b04453b61f1dbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0322b4b7bc80f68fc35836ef85f5889f |
| publicationDate |
2020-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3254695-B1 |
| titleOfInvention |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3791896-A1 |
| priorityDate |
2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |